Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2014 by Synta Pharmaceuticals Corp..
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Synta Pharmaceuticals Corp. Identifier:
First received: May 28, 2008
Last updated: September 17, 2014
Last verified: September 2014
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)